Bufexamac (Compound)

Synonyms:bufexamac, 2438-72-4, Bufexamic acid, 2-(4-Butoxyphenyl)-N-hydroxyacetamide, Parfenac, Droxaryl, Feximac, Malipuran, Mofenar, Norfemac, Parfenal, 4-Butoxy-N-hydroxybenzeneacetamide, Bufexamaco, Bufexamacum, Flogicid, p-Butoxyphenylacetohydroxamic acid, Paraderm, 4-Butoxyphenylacetohydroxamic acid, Anderm, Flogocid N plastigel, 2-(p-Butoxyphenyl)-acetohydroxamic acid, Acide p-butoxyphenylacethydroxamique, 2-(p-Butoxyphenyl)acetohydroxamic acid, CP 1044 J3, UNII-4T3C38J78L, CP 1044, CHEBI:31317, ACETOHYDROXAMIC ACID, 2-(p-BUTOXYPHENYL)-, 2-(4-butoxyphenyl)acetohydroxamic acid, CHEMBL94394, MLS000028409, 4T3C38J78L, J3, NCGC00016611-01, SMR000058407, CAS-2438-72-4, DSSTox_CID_25368, DSSTox_RID_80831, DSSTox_GSID_45368, Bufessamac [DCIT], Bufessamac, Droxarol, ML392, Bufexamacum [INN-Latin], Bufexamaco [INN-Spanish], Benzeneacetamide, 4-butoxy-N-hydroxy-, Bufexamac [INN:BAN:DCF:JAN], SR-01000003067, EINECS 219-451-1, BRN 2646848, Acide p-butoxyphenylacethydroxamique [French], Bufexamac,(S), Prestwick_676, Anderm (TN), Spectrum_001754, Bufexamac (JAN/INN), Opera_ID_1503, Prestwick0_000243, Prestwick1_000243, Prestwick2_000243, Prestwick3_000243, Spectrum2_001457, Spectrum3_000938, Spectrum4_001037, Spectrum5_001117, Epitope ID:180855, cid_2466, REGID_for_CID_2466, SCHEMBL25215, BSPBio_000026, KBioGR_001593, KBioSS_002234, MLS001148632, Bufexamac, analytical standard, Butoxyphenylacethydroxamic Acid, DivK1c_000108, SPECTRUM1502003, SPBio_001353, SPBio_002245, BPBio1_000030, GTPL7498, DTXSID7045368, BENZYLCHLOROACETYLCARBAMATE, HMS500F10, KBio1_000108, KBio2_002234, KBio2_004802, KBio2_007370, KBio3_001976, NINDS_000108, HMS1568B08, HMS1921B18, HMS2095B08, HMS2235I13, HMS3371K16, HMS3656H16, HMS3712B08, HMS3885K03, KUC105648N, Pharmakon1600-01502003

Pubchem:PUBCHEM:2466

Id:2466

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Bufexamac's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Bufexamac.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Bufexamac.

Results found

Linked to

	Label	Description
	bufexamac positively regulates TPBG Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	bufexamac negatively regulates GREB1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	bufexamac positively regulates MSMO1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	bufexamac negatively regulates CDC25B Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	bufexamac negatively regulates MRPS16 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	bufexamac in similarity relationship with [6-Hydroxy-2-(4-hydroxy-phenyl)-benzo[b]thiophen-3-yl]-[4-(4-isopropyl-piperazin-1-yl)-phenyl]-methanone Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	bufexamac positively regulates EZR Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	bufexamac positively regulates YME1L1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	bufexamac positively regulates PKM Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	bufexamac in similarity relationship with Ro-4987655 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS